Scarborough Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Scarborough Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-257	Closed	-$32.9K	–	708
2026 Q1	$32.9K	Hold	257	–	–	﹤0.01%	278
2025 Q4	$31.4K	Hold	257	–	–	0.01%	166
2025 Q3	$25.7K	Hold	257	–	–	﹤0.01%	173
2025 Q2	$21.3K	Buy	+257	New	+$20.5K	﹤0.01%	195
2024 Q3	–	Sell	-357	Closed	-$33.1K	–	455
2024 Q2	$33.1K	Hold	357	–	–	0.01%	123
2024 Q1	$33.8K	Hold	357	–	–	0.02%	124
2023 Q4	$31.8K	Buy	+357	New	+$26.5K	0.01%	220

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Scarborough Advisors's XBI Position: Q2 2026 in Review

Scarborough Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 257 shares — an estimated $32.9K sold.

Scarborough Advisors first reported a position in XBI in Q4 2023 and held it in 7 quarters. The position peaked at $33.8K in Q1 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Scarborough Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 257 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $32.9K.
Scarborough Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 7 quarters.
Scarborough Advisors's State Street SPDR S&P Biotech ETF position peaked at $33.8K in Q1 2024.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.